MetLife Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.8M | Buy |
|
|||||
|
2025
Q1 | $36.3M | Sell |
|
|||||
|
2024
Q4 | $30.5M | Buy |
|
|||||
|
2024
Q3 | $27.1M | Sell |
|
|||||
|
2024
Q2 | $22.8M | Buy |
|
|||||
|
2024
Q1 | $21.4M | Sell |
|
|||||
|
2023
Q4 | $24.5M | Sell |
|
|||||
|
2023
Q3 | $23.1M | Sell |
|
|||||
|
2023
Q2 | $24.4M | Sell |
|
|||||
|
2023
Q1 | $26.7M | Sell |
|
|||||
|
2022
Q4 | $28.1M | Sell |
|
|||||
|
2022
Q3 | $20.5M | Sell |
|
|||||
|
2022
Q2 | $20.9M | Sell |
|
|||||
|
2022
Q1 | $20.3M | Buy |
|
|||||
|
2021
Q4 | $20.1M | Sell |
|
|||||
|
2021
Q3 | $19.8M | Sell |
|
|||||
|
2021
Q2 | $20M | Sell |
|
|||||
|
2021
Q1 | $19.4M | Sell |
|
|||||
|
2020
Q4 | $17.7M | Sell |
|
|||||
|
2020
Q3 | $20.1M | Sell |
|
|||||
|
2020
Q2 | $25.2M | Buy |
|
|||||
|
2020
Q1 | $24.4M | Sell |
|
|||||
|
2019
Q4 | $21.8M | Sell |
|
|||||
|
2019
Q3 | $21.8M | Sell |
|
|||||
|
2019
Q2 | $23.7M | Sell |
|
|||||
|
2019
Q1 | $23.6M | Sell |
|
|||||
|
2018
Q4 | $23.1M | Sell |
|
|||||
|
2018
Q3 | $29.1M | Sell |
|
|||||
|
2018
Q2 | $27.1M | Sell |
|
|||||
|
2018
Q1 | $29.7M | Sell |
|
|||||
|
2017
Q4 | $29M | Buy |
|